FDAnews
www.fdanews.com/articles/114522-ucb-sells-anti-haemorrhagic-drug-to-eumedica

UCB Sells Anti-Haemorrhagic Drug to Eumedica

February 11, 2009
UCB announced that it has agreed to sell world-wide rights to its anti-haemorrhagic product Somatostatine-UCB to Eumedica.
The Earth Times